ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 79 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 5,555,461 | $5,416,574 | 2.98% |
| NEA Management Company, LLC | 17,079,778 | $16,651,076 | 1.25% |
| EcoR1 Capital, LLC | 27,404,070 | $26,716,228 | 0.82% |
| MPM BioImpact LLC | 5,095,912 | $4,968,514 | 0.77% |
| PFM Health Sciences, LP | 10,520,231 | $10,256,173 | 0.51% |
| Long Focus Capital Management, LLC | 12,346,417 | $12,036,522 | 0.46% |
| Matrix Capital Management Company, LP | 38,974,185 | $37,995,933 | 0.29% |
| Acuitas Investments, LLC | 541,201 | $527,617 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 1,743,619 | $1,699,854 | 0.17% |
| Key Client Fiduciary Advisors, LLC | 263,989 | $257,363 | 0.13% |